132 related articles for article (PubMed ID: 36823640)
21. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR.
Yu Z; Li N; Jiang K; Zhang N; Yao LL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5867-5873. PubMed ID: 30280766
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
[TBL] [Abstract][Full Text] [Related]
23. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.
Wu Z; Liu J; Hu S; Zhu Y; Li S
Cell Physiol Biochem; 2018; 45(2):808-818. PubMed ID: 29414823
[TBL] [Abstract][Full Text] [Related]
24. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
[TBL] [Abstract][Full Text] [Related]
25. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression.
Liu Y; Gu S; Li H; Wang J; Wei C; Liu Q
Biochem Biophys Res Commun; 2019 Oct; 518(1):127-133. PubMed ID: 31427084
[TBL] [Abstract][Full Text] [Related]
26. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
[TBL] [Abstract][Full Text] [Related]
27. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
[TBL] [Abstract][Full Text] [Related]
28. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.
Gao S; Wang K; Wang X
Neoplasma; 2020 Jul; 67(4):724-734. PubMed ID: 32726125
[TBL] [Abstract][Full Text] [Related]
29. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
30. Ginsenoside impedes proliferation and induces apoptosis of human osteosarcoma cells by down-regulating β-catenin.
Li XF; Zhao GQ; Li LY
Cancer Biomark; 2019; 24(4):395-404. PubMed ID: 30909183
[TBL] [Abstract][Full Text] [Related]
31. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
32. p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade.
Ding Y; Wang Y; Chen J; Hu Y; Cao Z; Ren P; Zhang Y
Tumour Biol; 2014 Apr; 35(4):3119-23. PubMed ID: 24323562
[TBL] [Abstract][Full Text] [Related]
33. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
Huang Z; Huang Y; He H; Ni J
Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
[TBL] [Abstract][Full Text] [Related]
34. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
[TBL] [Abstract][Full Text] [Related]
35. ITGB3 promotes cisplatin resistance in osteosarcoma tumors.
Li Q; Chen G; Jiang H; Dai H; Li D; Zhu K; Zhang K; Shen H; Xu H; Li S
Cancer Med; 2023 Apr; 12(7):8452-8463. PubMed ID: 36772869
[TBL] [Abstract][Full Text] [Related]
36. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
[TBL] [Abstract][Full Text] [Related]
37. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
[TBL] [Abstract][Full Text] [Related]
38. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
39. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
Li QC; Xu H; Wang X; Wang T; Wu J
Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
[TBL] [Abstract][Full Text] [Related]
40. Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
Zheng D; Wu W; Dong N; Jiang X; Xu J; Zhan X; Zhang Z; Hu Z
Mol Carcinog; 2017 Oct; 56(10):2234-2244. PubMed ID: 28543796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
